Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response

Cytotoxic T lymphocytes (CTL) can respond to a few viral peptide-MHC-I (pMHC-I) complexes among a myriad of virus-unrelated endogenous self pMHC-I complexes displayed on virus-infected cells. To elucidate the molecular recognition events on live CTL, we have utilized a self-assembled biosensor composed of semiconductor nanocrystals, quantum dots, carrying a controlled number of virus-derived (cognate) and other (noncognate) pMHC-I complexes and examined their recognition by antigen-specific T cell receptor (TCR) on anti-virus CD8+ T cells. The unique architecture of nanoscale quantum dot/pMHC-I conjugates revealed that unexpectedly strong multivalent CD8–MHC-I interactions underlie the cooperative contribution of noncognate pMHC-I to the recognition of cognate pMHC-I by TCR to augment T cell responses. The cooperative, CD8-dependent spread of signal from a few productively engaged TCR to many other TCR can explain the remarkable ability of CTL to respond to virus-infected cells that present few cognate pMHC-I complexes.

[1]  David I. Stuart,et al.  Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8αα* , 2000, The Journal of Biological Chemistry.

[2]  A. Lanzavecchia,et al.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.

[3]  C. Tournay,et al.  Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding , 2000, Nature Medicine.

[4]  M. Edidin,et al.  Vesicle trafficking and cell surface membrane patchiness. , 2001, Biophysical journal.

[5]  Arup K Chakraborty,et al.  CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse , 2004, Nature Immunology.

[6]  J. Cochran,et al.  Receptor Proximity, Not Intermolecular Orientation, Is Critical for Triggering T-cell Activation* , 2001, The Journal of Biological Chemistry.

[7]  Igor L. Medintz,et al.  Can luminescent quantum dots be efficient energy acceptors with organic dye donors? , 2005, Journal of the American Chemical Society.

[8]  M. Bawendi,et al.  (CdSe)ZnS Core-Shell Quantum Dots - Synthesis and Characterization of a Size Series of Highly Luminescent Nanocrystallites , 1997 .

[9]  B. Alarcón,et al.  Multivalent structure of an αβT cell receptor , 1999 .

[10]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[11]  Michael Loran Dustin,et al.  Cytotoxic T lymphocytes form an antigen-independent ring junction. , 2004, The Journal of clinical investigation.

[12]  R. Henderson,et al.  Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.

[13]  G. Gao,et al.  Antagonism of cytotoxic T-lymphocyte activation by soluble CD8 , 1999, Nature Medicine.

[14]  B K Jakobsen,et al.  Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. , 2000, Immunology today.

[15]  Ellis L. Reinherz,et al.  T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4* , 2001, The Journal of Biological Chemistry.

[16]  B. Walker,et al.  Major histocompatibility complex class I–intercellular adhesion molecule‐1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytes , 2004, Immunology.

[17]  Igor L. Medintz,et al.  Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. , 2003, Journal of the American Chemical Society.

[18]  Kuang-Yow Lian,et al.  Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  George F. Gao,et al.  Molecular coordination of αβ T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands , 2002 .

[20]  David M Kranz,et al.  Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. , 2003, Immunity.

[21]  Mark M. Davis,et al.  Direct observation of ligand recognition by T cells , 2002, Nature.

[22]  Jason E Gestwicki,et al.  Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. , 2002, Journal of the American Chemical Society.

[23]  N. Glaichenhaus,et al.  Generation and use of alternative multimers of peptide/MHC complexes. , 2002, Journal of immunological methods.

[24]  J. Matthew Mauro,et al.  Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein , 2000 .

[25]  Yuri Sykulev,et al.  Soluble HIV-specific T cell receptor: expression, purification and analysis of the specificity. , 2003, Journal of immunological methods.

[26]  T. Zal,et al.  Nonstimulatory peptides contribute to antigen-induced CD8–T cell receptor interaction at the immunological synapse , 2005, Nature Immunology.

[27]  Michael Loran Dustin,et al.  ICAM-1 co-stimulates target cells to facilitate antigen presentation. , 2005, Current opinion in immunology.

[28]  Mark M. Davis,et al.  Distinct molecular mechanisms account for the specificity of two different T-cell receptors. , 2003, Biochemistry.

[29]  Igor L. Medintz,et al.  Self-assembled nanoscale biosensors based on quantum dot FRET donors , 2003, Nature materials.

[30]  Igor L. Medintz,et al.  A hybrid quantum dot-antibody fragment fluorescence resonance energy transfer-based TNT sensor. , 2005, Journal of the American Chemical Society.

[31]  H. Eisen,et al.  Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.

[32]  M. Bawendi,et al.  Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites , 1993 .

[33]  S. Mark,et al.  CD8+ Cytotoxic T Lymphocyte Activation by Soluble Major Histocompatibility Complex-Peptide Dimers* , 2005, Journal of Biological Chemistry.

[34]  R. Young,et al.  Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.

[35]  Morgan Huse,et al.  Agonist/endogenous peptide–MHC heterodimers drive T cell activation and sensitivity , 2005, Nature.

[36]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[37]  B. Walker,et al.  An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B K Jakobsen,et al.  T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. , 1999, Immunity.

[39]  M. Edidin,et al.  Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. , 1994, Journal of immunology.